Table 4 Relations of three polymorphisms to the prevalence of hypertension analyzed with a generalized estimating equation (first wave to fourth wave)

From: Association of polymorphisms of SORBS1, GCK and WISP1 with hypertension in community-dwelling Japanese individuals

Gene symbol

Polymorphism

Subjects

Genotype

Hypertension

Control

P-value (dominant)

P-value (recessive)

SORBS1

682A → G (Thr228Ala)

      
  

Total

AA

1792 (76.5)

3818 (80.1)

0.0039

0.1749

   

AG

512 (21.9)

896 (18.8)

  
   

GG

39 (1.7)

55 (1.2)

  
  

Women

AA

847 (77.0)

1891 (80.6)

0.0249

0.3641

   

AG

227 (20.6)

417 (17.8)

  
   

GG

26 (2.4)

39 (1.7)

  
  

Men

AA

945 (76.0)

1927 (79.6)

0.0628

0.2649

   

AG

285 (22.9)

479 (19.8)

  
   

GG

13 (1.1)

16 (0.7)

  

GCK

−30G → A

      
  

Total

GG

1639 (69.7)

3006 (62.9)

0.0068

0.5414

   

GA

638 (27.1)

1597 (33.4)

  
   

AA

74 (3.1)

175 (3.7)

  
  

Women

GG

798 (72.3)

1463 (62.1)

0.0025

0.2016

   

GA

279 (25.3)

798 (33.9)

  
   

AA

27 (2.5)

95 (4.0)

  
  

Men

GG

841 (67.4)

1543 (63.7)

0.3861

0.7655

   

GA

359 (28.8)

799 (33.0)

  
   

AA

47 (3.8)

80 (3.3)

  

WISP1

2364A → G

      
  

Total

AA

895 (38.2)

1919 (40.2)

0.0184

0.4578

   

AG

1133 (48.3)

2219 (46.5)

  
   

GG

318 (13.6)

635 (13.3)

  
  

Women

AA

458 (41.7)

929 (39.5)

0.5437

0.2908

   

AG

526 (47.9)

1108 (47.1)

  
   

GG

115 (10.5)

315 (13.4)

  
  

Men

AA

437 (35.0)

990 (40.9)

0.0074

0.0597

   

AG

607 (48.7)

1111 (45.9)

  
   

GG

203 (16.3)

320 (13.2)

  
  1. The prevalence of hypertension was compared between two groups (dominant or recessive model) for each polymorphism, with adjustment for age and sex in all subjects or for age in women or men examined separately.
  2. Values in parentheses are percentages. P-values of <0.05 are shown in bold.